Physician profile
Paul Krafft
NPI 1366857245
$79,954.87
in general payments reported to CMS, 2019-2025
19 companies · $40K in 2025
The $40K reported for 2025 was more than what 94% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $43.32 · 2022: $7,538 · 2023: $12K · 2024: $21K · 2025: $40K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $61K · Travel and Lodging: $7,473 · Food and Beverage: $4,002.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $60,898.90 |
| Travel and Lodging | $7,472.56 |
| Food and Beverage | $4,001.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spine Wave, INC. | $29,475.00 | 2022-2025 | Exceed Biplanar Expandable Interbody System, Spinal Implant, Salvo Spine System |
| Si-Bone, INC. | $21,209.38 | 2021-2025 | |
| Elevation Spine, INC. | $13,851.02 | 2023-2025 | |
| Zavation Medical Products, LLC | $4,250.00 | 2022-2024 | |
| Medtronic, INC. | $2,881.72 | 2022-2025 | Unid_pass, Cd Horizon Spinal System, Infinity Occipitocervical Upper Thoracic System |
| Expanding Innovations, INC. | $1,866.37 | 2025 | X-Pac |
| Zimvie INC. | $1,779.17 | 2022 | |
| Alphatec Spine, INC | $1,228.38 | 2025 | Other - Miscellaneous |
| Medical Device Business Services, INC. | $1,203.96 | 2022 | |
| Globus Medical, INC. | $1,175.27 | 2022 | |
| Depuy Synthes Sales INC. | $262.94 | 2022-2023 | Sentio |
| Stryker Corporation | $159.26 | 2022 | |
| Integra Lifesciences Corporation | $128.29 | 2022 | |
| Zimmer Biomet Holdings, INC. | $127.18 | 2022 | |
| Kci USA, INC. | $126.50 | 2023 | Prevena, V.A.C. Veraflo, V.A.C. Veraflo Cleanse Choice |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biocomposites INC | $109.33 | 2025 | Stimulan |
| Orthofix Medical, INC. | $70.34 | 2023 | Spinal-Stim, Spinal-Stim |
| Abbvie INC. | $29.08 | 2024 | |
| Adc Therapeutics America, INC. | $21.68 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$2,997.80 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Krafft listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.